Company: PSTV
Filing Date: 2025-08-12
Form Type: S-1
Source: 0001193125-25-178940
Chunk: 54

Company: PLUS THERAPEUTICS, INC.
Filing Date: 2025-08-12
Form: S-1
Chunk 54
---
, his true and lawful attorneys-in-fact and agents, with full power of substitution and re-substitution, for him and in his name, place and stead, in any and all capacities, to sign any and all amendments, including post-effective amendments, to this Registration Statement, and any registration statement relating to the offering covered by this Registration Statement and filed pursuant to Rule 462(b) under the Securities Act of 1933, and to file the same, with exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done, as fully for all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that each of said attorneys in fact and agents or their substitute or substitutes may lawfully do or cause to be done by virtue hereof. Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.

| Name                        
 /s/ Marc H. Hedrick, MD     
 Marc H. Hedrick, MD         
 /s/ Andrew Sims             
 Andrew Sims                 |     | Title                                              
 President and Chief Executive Officer and Director 
 (Principal Executive Officer)                      
 Chief Financial Officer (Principal Financial       
 Officer and Principal Accounting Officer)          |     | Date            
 August 12, 2025 
 August 12, 2025 |
|:----------------------------|:----|:---------------------------------------------------|:----|:----------------|
| /s/ Richard J. Hawkins      
 Richard J. Hawkins          |     | Chairman of the Board                              |     | August 12, 2025 |
| /s/ Howard Clowes           
 Howard Clowes               |     | Director                                           |     | August 12, 2025 |
| /s/ Kyle Guse               
 Kyle Guse                   |     | Director                                           |     | August 12, 2025 |
| /s/ An van Es-Johansson, MD 
 An van Es-Johansson, MD     |     | Director                                           |     | August 12, 2025 |
| /s/ Robert Lenk, Ph.D.      
 Robert Lenk, Ph.D.          |     | Director                                           |     | August 12, 2025 |

II-10